X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

IMMUNOLOGY

期刊標題檢索 IMMUNOLOGY 最新評論: Excuse me, friend, what step are we at now? (2025-11-22)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[IMMUNOLOGY]您好,您是該頁面的第 113625 位訪客。

期刊簡介
期刊名稱IMMUNOLOGY IMMUNOLOGY
LetPub Score
7.5
50 ratings
Rate

Reputation
8.8

Influence
6.5

Speed
7.1

期刊簡稱IMMUNOLOGY
ISSN0019-2805
E-ISSN1365-2567
h-index117
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.001.7561.175
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Immunology and Allergy
Q141 / 231
Category: Medicine
Subcategory: Immunology
Q145 / 240

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Immunology is one of the longest-established immunology journals and is recognised as one of the leading journals in its field. We have global representation in authors, editors and reviewers.

Immunology publishes papers describing original findings in all areas of cellular and molecular immunology. High-quality original articles describing mechanistic insights into fundamental aspects of the immune system are welcome. Topics of interest to the journal include: immune cell development, cancer immunology, systems immunology/omics and informatics, inflammation, immunometabolism, immunology of infection, microbiota and immunity, mucosal immunology, and neuroimmunology.

The journal also publishes commissioned review articles on subjects of topical interest to immunologists, and commissions in-depth review series: themed sets of review articles which take a 360° view of select topics at the heart of immunological research.
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2567
在線稿件提交https://mc.manuscriptcentral.com/imm
開放訪問No
出版商Wiley-Blackwell Publishing Ltd
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年0
每年文章數117每年文章數趨勢
黃金OA百分比29.33%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ144/183
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0019-2805%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【IMMUNOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 84.70
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 38.20
    Annual Review of ImmunologyH-index: 279

    CiteScore: 55.50
    ImmunityH-index: 355

    CiteScore: 40.80
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 36.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 21.20
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 22.10
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 16.80
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 15.20
    Mucosal ImmunologyH-index: 82

    CiteScore: 16.50
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology518264
    JOURNAL OF IMMUNOLOGY161421
    MOLECULAR IMMUNOLOGY116414
    Immunity113030
    Cellular & Molecular Immunology112968
    MEDIATORS OF INFLAMMATION112247
    MICROBIAL PATHOGENESIS109564
    Vaccine109499
    JOURNAL OF EXPERIMENTAL MEDICINE108205
    INFLAMMATION102854
  •  

    IMMUNOLOGY IMMUNOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [IMMUNOLOGY] 的評論撰寫評論
作者: 藤原炳钛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-13 10:26:32 評論於
My submission was rejected, and it took almost a month to get a response. They didn't even send it for review
(0) 讚! | 藤原炳钛

作者: 无冬南阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-27 10:04:01 評論於
Review Speed: 6.0 | Submission Acceptance Rate: 25.0
Emphasized Research Direction: Immunology
Experience Sharing: Received review suggestions 3 and a half months after submission. The reviewer was rigorous and serious, with a high level of expertise. The review comments were pertinent and to the point. The editor provided an opportunity for revision, and the manuscript is currently in revision status. Hoping for good luck
(0) 讚! | 无冬南阳

作者: 重阳兴文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-19 20:59:07 評論於
I also checked on ScholarOne, and I am still in with the editorial office after a week. Have you heard any news?
(0) 讚! | 重阳兴文

作者: 重阳兴文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-19 09:41:35 評論於
Has yours been under review? Mine has been in ScholarOne for a week and is still with the editorial office
(0) 讚! | 重阳兴文

作者: 重阳兴文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-18 15:38:15 評論於
I checked the submission status on ScholarOne and it still says "with editorial office" after a week. Can experienced scholars confirm if this is normal?
(0) 讚! | 重阳兴文

作者: 重阳兴文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-14 15:48:07 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 95.0
Experience Sharing
(0) 讚! | 重阳兴文

作者: 龙鳞奕洳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-14 15:27:05 評論於
It's not Ha
(0) 讚! | 龙鳞奕洳

作者: 藤原炳钛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-08 23:30:36 評論於
Are you looking on Scholarone?
(0) 讚! | 藤原炳钛

作者: 无冬南阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-08 13:07:14 評論於
I nuder review in just 3 days
(0) 讚! | 无冬南阳

作者: 无冬南阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-07 18:12:23 評論於
Submission is faster, but review is slower
(0) 讚! | 无冬南阳

作者: 藤原炳钛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-07 15:33:51 評論於
Is the review process really fast? How long did it take for you to submit?
(0) 讚! | 藤原炳钛

作者: 藤原炳钛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-27 12:23:17 評論於
Has it been a week since you submitted your work to the editorial office?
(0) 讚! | 藤原炳钛

作者: 无冬南阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-24 18:23:51 評論於
Are you back?
(0) 讚! | 无冬南阳

作者: 无冬南阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-15 21:55:06 評論於
Has the revised manuscript come back?
(0) 讚! | 无冬南阳

作者: 无冬南阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-06 16:01:48 評論於
Have the review comments come back?
(0) 讚! | 无冬南阳

作者: 凝芙三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-15 12:06:16 評論於
The impression is uploaded separately
(0) 讚! | 凝芙三岁啦

作者: 凝芙三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-15 11:49:08 評論於
No layout fee
(0) 讚! | 凝芙三岁啦

作者: 佁然来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-21 17:16:12 評論於
Okay, thank you for the reply
(0) 讚! | 佁然来了

作者: 佁然来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-21 15:11:56 評論於
Over four months have passed
(0) 讚! | 佁然来了

作者: 佁然来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-15 20:28:19 評論於
Hello, is there a requirement to provide both the Graphical Table and corresponding three-sentence summary at the time of rework?
(0) 讚! | 佁然来了

作者: 白云波鸿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-15 20:25:18 評論於
Hello, may I ask when will you receive the results of the external audit?
(0) 讚! | 白云波鸿

作者: 佁然来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-15 13:35:02 評論於
Hello, is there a requirement to provide both the Graphical Table and corresponding three-sentence summary at the same time during rework?
(0) 讚! | 佁然来了

作者: 六合建珍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-15 09:21:53 評論於
No
(0) 讚! | 六合建珍

作者: 佁然来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-15 08:33:51 評論於
Hello, is there a requirement to provide both the Graphical Table and the corresponding three-sentence summary at the same time during rework?
(0) 讚! | 佁然来了

作者: 疯魔幼萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-13 08:45:21 評論於
Wait, it's been over a month since my second review and I've provided some minor suggestions and edits for coordination, it's been back and forth for over two months now. The editor is dragging their feet, I don't know if it's because they have changed staff since becoming independent from the British Immunology Society
(0) 讚! | 疯魔幼萱

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [IMMUNOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*